Betamethasone dipropionate (Compound)
Synonyms:BETAMETHASONE DIPROPIONATE, Diprolene, Diprosone, 5593-20-4, Alphatrex, Maxivate, Diprolene AF, Diproderm, Psorion, Betamethasone 17,21-dipropionate, Rinderon DP, Diprosis, Diprospan, Sch 11460, Sch-11460, S-3440, Betamethasone (as dipropionate), Betamethasone-17,21-dipropionate, DTXSID2022672, CHEBI:31276, 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate, NSC-758415, Pregna-1,4-diene-3,20-dione,9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11b,16b)-, 826Y60901U, [2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate, (11-beta,16-beta)-9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione, 9-fluoro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate, 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17,21-dipropionate, beta-Methasone 17,21-dipropionate, EINECS 227-005-2, BRN 3638108, .beta.-Methasone 17,21-dipropionate, Betamethasone Dipropionate (Diprolene), S 3440, Diprolene (TN), UNII-826Y60901U, NCGC00159360-02, NCGC00159443-02, Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11.beta.,16.beta.)-, Sernivo (TN), Rinderon-DP (TN), Betamethasone dipropionate [USAN:USP:JAN], betamethasone-dipropionate, BETAMETHASONE DIPROP, SCHEMBL7519, 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-di(propionate), Betamethasone-17,21-dipropionate 100 microg/mL in Acetonitrile, DTXCID302672, CHEMBL1200384, component of Betasone (Salt/Mix), component of Alphatrex (Salt/Mix), AMY22130, Tox21_113343, BDBM50421892, s1688, AKOS015969733, Betamethasone dipropionate (JP17/USP), CCG-269732, CS-7549, KS-5303, NSC 758415, BETAMETHASONE DIPROPIONATE [JAN], BETAMETHASONE DIPROPIONATE [USAN], NCGC00159443-01, NCGC00159443-05, 2-((2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-2,13,15-trimethyl-5-oxo -14-propanoyloxytetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl)-2-o xoethyl propanoate, BETAMETHASONE DIPROPIONATE [MART.], BETAMETHASONE DIPROPIONATE [VANDF], HY-13571, Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-, 17,21-dipropionate, Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11beta,16beta), BETAMETHASONE DIPROPIONATE [USP-RS], BETAMETHASONE DIPROPIONATE [WHO-DD], CAS-5593-20-4, BETAMETHASONE DIPROPIONATE, AUGMENTED, B3166, BETAMETHASONE 17,21-DIPROPIONATE [MI], BETAMETHASONE DIPROPIONATE [GREEN BOOK], BETAMETHASONE DIPROPIONATE [ORANGE BOOK], D01637, AB01274713-01, AB01274713_02, BETAMETHASONE 17.ALPHA.,21-DIPROPIONATE, BETAMETHASONE DIPROPIONATE [EP MONOGRAPH], BETAMETHASONE DIPROPIONATE [USP MONOGRAPH], WYNZORA COMPONENT BETAMETHASONE DIPROPIONATE, ENSTILAR COMPONENT BETAMETHASONE DIPROPIONATE, LOTRISONE COMPONENT BETAMETHASONE DIPROPIONATE, Q4897349, TACLONEX COMPONENT BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE COMPONENT OF ENSTILAR, BETAMETHASONE DIPROPIONATE COMPONENT OF TACLONEX, BETAMETHASONE DIPROPIONATE COMPONENT OF WYNZORA, BRD-K58148589-001-03-6, LEO-90100 COMPONENT BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE COMPONENT OF LOTRISONE, BETAMETHASONE DIPROPIONATE COMPONENT OF LEO-90100, (11.beta.,16.beta.)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate, (11beta,16beta)-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate, 9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate, 9-Fluoro-11.beta.-hydroxy-16.beta.-methyl-3,20-dioxo-17-(propionyloxy)pregna-1,4-dien-21-yl propionate #, 9alpha-Fluoro-11beta,17alpha,21-trihydroxy-16beta-methyl-1,4-pregnadiene-3,20-dione 17,21-Dipropionate, 9alpha-fluoro-11beta,17alpha,21-trihydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene- 17,21-diyl dipropionate, Pregna-1,4-diene-3,20-dione, 9-fluoro-11-.beta.,17,21-trihydroxy-16-.beta.-methyl-,17,21-dipropionate, PREGNA-1,4-DIENE-3,20-DIONE, 9-FLUORO-11-HYDROXY-16-METHYL-17,21-BIS(1-OXOPROPOXY)-, (11.BETA.,16.BETA.)
Pubchem:PUBCHEM:21800
Id:a646fae2-046d-59d0-9e88-a6ca11fa50aa
Analyze
CFDE DD-Knowledge Graph
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Betamethasone dipropionate's neighborhood in the knowledge graph.
GDLPA Landing Pages Links
The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Betamethasone dipropionate.
Playbook Workflow Builder
The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Betamethasone dipropionate.
Results found
Linked to
| Label | Description |
|
|---|---|---|---|
 | A Substance | ||
 | A Knowledge Graph Assertion from IDG | ||
| A Knowledge Graph Assertion from IDG | ||
| A Knowledge Graph Assertion from IDG | ||
| A Knowledge Graph Assertion from IDG | ||
| A Knowledge Graph Assertion from IDG | ||
| A Knowledge Graph Assertion from IDG | ||
| A Knowledge Graph Assertion from IDG | ||
| A Knowledge Graph Assertion from IDG | ||
| A Knowledge Graph Assertion from IDG |
A Knowledge Graph Assertion from IDG
A Knowledge Graph Assertion from IDG
A Knowledge Graph Assertion from IDG
A Knowledge Graph Assertion from IDG
A Knowledge Graph Assertion from IDG
A Knowledge Graph Assertion from IDG
A Knowledge Graph Assertion from IDG
A Knowledge Graph Assertion from IDG
A Knowledge Graph Assertion from IDG
DISPLAY PER PAGE
10
@CFDE Workbench 2025
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
@CFDE Workbench 2025